---
audienceLevel: patient
cancerTypes:
- colorectal
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: FOLFIRI-BEVACIZUMAB - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/folfiri-bevacizumab
version: v1
---

# FOLFIRI-BEVACIZUMAB - NCI

# FOLFIRI-BEVACIZUMAB

Placeholder slot

(... beh-vuh-SIH-zoo-mab)

This combination contains the chemotherapy drugs leucovorin calcium (folinic acid), fluorouracil, and irinotecan hydrochloride and the targeted therapy drug bevacizumab. Combinations usually work better than single drugs because
different drugs kill
cancer
cells in different ways.

Drugs in the FOLFIRI-BEVACIZUMAB combination:

|  |  |
| --- | --- |
| **FOL** | = [Leucovorin Calcium](/about-cancer/treatment/drugs/leucovorincalcium) (Folinic Acid) |
| **F** | = [Fluorouracil](/about-cancer/treatment/drugs/fluorouracil) |
| **IRI** | = [Irinotecan Hydrochloride](/about-cancer/treatment/drugs/irinotecanhydrochloride) |
|  | + [Bevacizumab](/about-cancer/treatment/drugs/bevacizumab) |

Each of the
drugs
in this
combination
is approved by the
[Food and Drug
Administration (FDA)](/Common/PopUps/popDefinition.aspx?id=454785&version=Patient&language=English)
to treat
cancer
or conditions related to cancer.

## Use in Cancer

FOLFIRI-BEVACIZUMAB is used to treat:

- **[Colorectal cancer](/Common/PopUps/popDefinition.aspx?id=444983&version=Patient&language=English)** that has [metastasized](/Common/PopUps/popDefinition.aspx?id=46283&version=Patient&language=English) (spread to other parts of the body).

This combination may also be used with other drugs or treatments or to treat other types of cancer.

## More About FOLFIRI-BEVACIZUMAB

[Definition from the NCI Drug Dictionary](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/657060) - Detailed scientific definition and other names for this drug.
